Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

NCT04598919 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis (IPF)

Interventions

DRUG: Saracatinab
DRUG: Placebo

Sponsor

National Jewish Health

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]